돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 61595생성일: 2026년 10월 24일

Ethylamine hydrochloride → 2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-ethylacetamide

https://huagongshe.com/reaction/61595

반응식

참여 물질

역할이름HCID투입량
반응물Ethylamine hydrochlorideHCID 11198—
반응물DiisopropylethylamineHCID 81531—
반응물PyBOPHCID 2724699—
반응물2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)acetic acidHCID 59361988—
용매DimethylformamideHCID 6228—
용매DichloromethaneHCID 6344—
생성물2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-ethylacetamideHCID 11950520—

반응 단계

A suspension of 2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)acetic acid (70 mg, 0.14 mmol), PyBOP® (40 mg, 0.077 mmol), DIEA (24 μL, 0.14 mmol) in dry CH2Cl2:DMF (2:0.1 mL) was stirred at RT for 15 minutes. To this solution of activated acid was added ethanamine hydrochloride (7.4 mg, 0.091 mmol). After 30 minutes, 1.0 equivalent of DIEA and 0.55 equivalents of PyBOP® were added. After stirring the solution for 15 minutes, 0.65 equivalents of ethanamine hydrochloride were added and the mixture was stirred for an additional 30 minutes. The solvent was removed in vacuo and the crude product was purified using prep HPLC (15-40_90 mins) to afford 2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-ethylacetamide. (19 mg, 0.043 mmol, 31%)

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09440961B2
출처 데이터셋uspto-grants-2016_09
ORD IDord-8bfc6504422f4c7195a02e79c3a60c51
출처 메모uspto-grants-2016_09